Intimation of Schedule of the Investor/Analysts Conference Call (group meet)
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals Limited has disclosed an upcoming physical investor/analyst conference call scheduled for 1st June 2026 at 09:00 AM IST at Grand Hyatt, Mumbai. The company will participate in a group meet titled 'Rising Stars'. The filing explicitly states that no unpublished price sensitive information (UPSI) will be shared during the meet. The company cited that the decision process took longer than anticipated as the reason for late intimation. This disclosure is made pursuant to SEBI Listing Regulations.
This is a routine compliance filing indicating normal investor relations activity. No material information is being shared, so the filing should have minimal direct impact on the stock. The company is being transparent about its investor engagement schedule.